Pierre EV/EBIT
Was ist das EV/EBIT von Pierre?
EV/EBIT von Pierre Corp. ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Health Care Sektor auf NYSEMKT im Vergleich zu Pierre
Was macht Pierre?
Fourth Wave Energy, Inc. operates as a climate tech company. The company designs energy system to reduce energy consumption and associated carbon emissions in residences and commercial buildings. Its energy system is based on combining solar power and other energy technologies into one fully integrated system. The company is headquartered in San Jose, California.
Unternehmen mit ev/ebit ähnlich Pierre
- Microbot Medical Inc hat EV/EBIT von N/A
- Penbar Capital Ltd hat EV/EBIT von N/A
- Future Consumer hat EV/EBIT von N/A
- Orgenesis Inc hat EV/EBIT von N/A
- Sejal Glass hat EV/EBIT von N/A
- Castlight Health Inc hat EV/EBIT von N/A
- Pierre hat EV/EBIT von N/A
- Genfit SA hat EV/EBIT von N/A
- Fangdd Network Ltd hat EV/EBIT von N/A
- Achiko AG hat EV/EBIT von N/A
- Calithera Biosciences Inc hat EV/EBIT von N/A
- UroGen Pharma Ltd hat EV/EBIT von N/A
- Magenta Therapeutics Inc hat EV/EBIT von N/A